Resorbable Vascular Scaffolds Market Research Reveals Strong 12.3% CAGR Outlook Through 2030

The resorbable vascular scaffolds market is poised for significant expansion in the coming years, driven by advances in cardiovascular treatment options and growing interest in innovative medical technologies. This overview explores the expected market size, key players, emerging trends, and segmentation insights that define this evolving industry.

Forecasted Growth and Market Outlook for Resorbable Vascular Scaffolds
The global resorbable vascular scaffolds market is projected to reach $0.92 billion by 2030, registering a robust compound annual growth rate (CAGR) of 12.3% during the forecast period. This surge is fueled by a rising preference for safer alternatives to permanent stents, increased investments in cardiovascular device innovation, and expanding research into bioresorbable materials. Additionally, there is a growing emphasis on personalized treatment approaches, supported by favorable regulatory conditions promoting advanced vascular technologies. Key trends shaping the market include the development of bioabsorbable scaffold materials, adoption of next-generation vascular implants, focus on temporary vessel support, expansion of clinical trials, and a stronger focus on improving long-term patient outcomes.

The resorbable vascular scaffolds market size has grown rapidly in recent years. It will grow from $0.51 billion in 2025 to $0.58 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to advancements in polymer-based medical materials, increasing prevalence of cardiovascular diseases, expansion of interventional cardiology procedures, growing adoption of minimally invasive treatments, availability of clinical evidence supporting scaffold use.

Download a free sample of the resorbable vascular scaffolds market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21272&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Current Market Leaders in Resorbable Vascular Scaffolds
Several prominent companies dominate the resorbable vascular scaffolds market, including Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Biotronik, Lepu Medical Technology, Biosensors International, Blue Medical, Reva Medical, Elixir Medical, S3V Vascular Technologies, Amaranth Medical Inc., Meril Life Sciences Pvt. Ltd., Arterius Limited, Zorion Medical, Kyoto Medical Planning Co. Ltd., ICON Interventional Systems, MicroPort Scientific Corporation, Cook Medical, Cardinal Health Interventional Division, Medinol Ltd., Alvimedica, and OrbusNeich Medical. In a notable move in April 2023, Abbott Laboratories acquired Cardiovascular Systems Inc., a company specializing in innovative atherectomy devices for peripheral and coronary artery diseases. This acquisition is set to broaden Abbott's vascular treatment portfolio and enhance patient care options.

Emerging Trends Shaping the Resorbable Vascular Scaffolds Market
Leading companies in this sector are actively developing magnesium-based scaffolds to enhance biocompatibility and mechanical performance. Magnesium scaffolds encourage natural vessel healing while minimizing inflammation and complications often linked to traditional polymer scaffolds. For example, in March 2024, Biotronik obtained FDA breakthrough device designation for its Freesolve below-the-knee (BTK) resorbable magnesium scaffold. This device is designed to support patients with chronic limb-threatening ischemia, offering improved safety, deliverability, and vessel support through its BIOmag magnesium alloy and Orsiro drug-eluting stent coating technologies. The scaffold provides crucial short-term support to prevent vessel recoil during healing.

View the full resorbable vascular scaffolds market report:
https://www.thebusinessresearchcompany.com/report/resorbable-vascular-scaffolds-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Detailed Segmentation of the Resorbable Vascular Scaffolds Market
This report breaks down the resorbable vascular scaffolds market into several key segments:
1) Product Design - including multilumen and single lumen types
2) Material Type - comprising Poly-Glycolic Acid, Poly-L-Lactic Acid, and Poly-L-Lactic-Co-Glycolic Acid
3) Deployment Technique - divided into balloon-expandable and self-expandable categories
4) Application - covering coronary artery disease, peripheral vascular disease, and pulmonary artery disease
5) End User - targeting ambulatory surgical centers, hospitals, and specialty clinics

Further subcategories delve into design specifics such as helical, braided, and other multilumen designs, alongside straight tube, corrugated tube, and alternative single lumen configurations.

Key enhancements in our 2026 market reports include:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.